Data as of Dec 19
 +0.02 / +1.74%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Curis, Inc. is a drug development company, which is committed to leveraging its innovative signaling pathway drug technologies to seek to create new targeted small molecule drug candidates for cancer. The company conducts research programs both internally and through strategic collaborations. The company was founded on February 14, 2000 and is headquartered in Lexington, MA.

Contact Information

Curis, Inc.
4 Maguire Road
Lexington Massachusetts 02421
P:(617) 503-6500
Investor Relations:
(617) 503-6605



Individual stakeholders9.87%
Other institutional31.61%
Mutual fund holders10.22%

Top Executives

Ali FattaeyPresident, Chief Executive Officer & Director
Michael P. GrayCFO, Secretary, Treasurer & Chief Business Officer
Jaye VinerChief Medical Officer & Executive Vice President
Mark W. NoelVP-Technology Management & Intellectual Property
Tania ChanderVice President-Product Development

To view my watchlist

Not a member yet?

Sign up now for a free account

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2014 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2014. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2014 and/or its affiliates.